For the Inventor, By the Inventor

Enter assignee name

London, United Kingdom

Helperby Therapeutics Limited

USPTO Granted Patents = 17

CIPO Patents = 6

EPO Patents = 17

Forward Citations = 52

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Yanmin Hu (16 out of 16 patents)

Anthony Coates (10 out of 10 patents)

Anthony R M Coates (4 out of 4 patents)

4. Hazel Joan Dyke (4 out of 32 patents)

5. Thomas David Pallin (4 out of 30 patents)

6. Marc Barry Brown (3 out of 35 patents)

7. David Edward Clark (3 out of 26 patents)

8. Keith Mills (3 out of 3 patents)

9. Gary Patrick Reid (3 out of 5 patents)

10. Petra Helga Beck (3 out of 3 patents)

11. Gerlinda Stoddart (3 out of 3 patents)

12. Derek John Londesbrough (3 out of 11 patents)

13. Anthony Robert Milnes Coates (2 out of 4 patents)

14. Anthony M R Coates (1 out of 1 patent)

15. Mandy Christine Beswick (1 out of 5 patents)

17 patents: Sort by Forward Citations

1. 11951119 - Combination comprising zidovudine and an antimicrobial compound (2024-04-09),

2. 10888575 - Combination comprising zidovudine and a carbapenem (2021-01-12),

3. 10736888 - Triple combination (2020-08-11),

4. 10493071 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2019-12-03),

5. 10335454 - Combination and use (2019-07-02),

6. 10265373 - Pharmaceutical composition and method of treating a microbial infection with sulcotidil (2019-04-23),

7. 10098904 - Zidovudine combination therapies for treating microbial infections (2018-10-16),

8. 9789101 - Methods and compositions for treating microbial infection using pyrroloquinone (2017-10-17),

9. 9757427 - Combination comprising zidovudine and polymyxin (2017-09-12),

10. 9694006 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2017-07-04),

11. 9549965 - Pharmaceutical composition for treating a microbial infection (2017-01-24),

12. 9216186 - Combination of a pyrroloquinoline compound and an aminoglycodise antimicrobial agent (2015-12-22),

13. 8940723 - Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine (2015-01-27),

14. 8759348 - Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms (2014-06-24),

15. 8207187 - Use of pyrroloquinoline compounds to kill clinically latent microorganisms (2012-06-26),

Helperby Therapeutics Limited is a biotechnology company focused on developing novel antibacterial drugs. With a mission to combat antibiotic resistance, Helperby Therapeutics specializes in optimizing existing antibiotics to improve their therapeutic potential. They employ innovative strategies and technologies to create next-generation antibiotics that effectively treat drug-resistant infections. Through their research and development efforts, Helperby Therapeutics aims to make a significant impact on public health by addressing the global threat of antibiotic resistance.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#184 in

#1,053 in

#34,856 in the World

London, United Kingdom

Helperby Therapeutics Limited

Forward Citations = 52

16 inventors:

Yanmin Hu (16 out of 16 patents)

Anthony Coates (10 out of 10 patents)

Anthony R M Coates (4 out of 4 patents)

4. Hazel Joan Dyke (4 out of 32 patents)

5. Thomas David Pallin (4 out of 30 patents)

Please report any incorrect information to support@idiyas.com

Loading…